Used primarily in research to inhibit the formation of advanced glycation end-products (AGEs), which are implicated in diabetic complications such as neuropathy, retinopathy, and nephropathy. It acts by scavenging reactive carbonyl species that form AGEs, thus protecting tissues from oxidative damage and inflammation. Investigated for potential therapeutic use in diabetes-related disorders and age-related diseases. Also employed in biochemical studies to block nitric oxide synthase, helping researchers understand nitric oxide pathways. Additionally, used in the synthesis of pharmaceuticals and agrochemicals as a building block for heterocyclic compounds.